Organoid of ovarian cancer: genomic analysis and drug screening.

Abstract Ovarian cancer is the most common malignant tumors of the female reproductive system, and its standard treatments are cytoreductive surgery and platinum-based adjuvant chemotherapy. Great advances have been achieved in novel treatment strategies, including targeted therapy and immunotherapy. However, ovarian cancer has the highest mortality rate among gynecological […]

View Original Source at Organoid of ovarian cancer: genomic analysis and drug screening.